Waqoo (4937) · InitiativeAchieved
Share exchange to make Cellpro Japan a wholly owned subsidiary
First written in FY2023. 1 of 2 entries say "Achieved", first in FY2024-Q1. Latest entry: FY2024-Q1.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Making セルプロジャパン a wholly owned subsidiary through a share exchangeA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2024-Q1AchievedAnnual report
「Effective 1 January 2024, we conducted a share exchange under which the company became the wholly owning parent company and Cellpro Japan Co., Ltd. became a wholly owned subsidiary.」
The planned full subsidiarization of Cellpro Japan was completed on 1 January 2024, giving the company 100% voting rights. The company issued 598,400 shares. - FY2023First statedAnnual report
「At a Board of Directors meeting held on 20 November 2023, we resolved to conduct a share exchange under which the company would become the wholly owning parent company and Cellpro Japan Co., Ltd. would become a wholly owned subsidiary, and the two companies entered into a share-exchange agreement on the same date.」
The company signed a share-exchange agreement to make Cellpro Japan, its regenerative-medicine partner, a wholly owned subsidiary, with the transaction scheduled to take effect on 1 January 2024 and 598,400 company shares to be delivered.